UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 321

Sortiert nach

Infectious complications in out-of-hospital cardiac arrest patients in the therapeutic hypothermia era

Critical care medicine, 2011-06, Vol.39 (6), p.1359-1364

2011

Volltextzugriff (PDF)

Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19

International journal of molecular sciences, 2021-07, Vol.22 (14), p.7462

2021

Volltextzugriff (PDF)

Impact of colonization with multidrug-resistant bacteria on the risk of ventilator-associated pneumonia in septic shock

Journal of critical care, 2022-10, Vol.71, p.154068-154068, Article 154068

2022

Volltextzugriff (PDF)

End of life decisions in immunocompromised patients with acute respiratory failure

Journal of critical care, 2022-12, Vol.72, p.154152-154152, Article 154152

2022

Volltextzugriff (PDF)

Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study

American journal of hematology, 2016-12, Vol.91 (12), p.1246-1251

2016

Volltextzugriff (PDF)

Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma

Oncogene, 2002-09, Vol.21 (43), p.6587-6597

2002

Volltextzugriff (PDF)

Impact of early ICU admission for critically ill cancer patients: Post-hoc analysis of a prospective multicenter multinational dataset

Journal of critical care, 2021-04, Vol.62, p.6-11

2021

Volltextzugriff (PDF)

Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality

Journal of thrombosis and haemostasis, 2021-07, Vol.19 (7), p.1823-1830

2021

Volltextzugriff (PDF)

Sepsis-induced expansion of granulocytic myeloid-derived suppressor cells promotes tumour growth through Toll-like receptor 4

The Journal of pathology, 2016-08, Vol.239 (4), p.473-483

2016

Volltextzugriff (PDF)

Lupus Anticoagulant Single Positivity During the Acute Phase of COVID‐19 Is Not Associated With Venous Thromboembolism or In‐Hospital Mortality

Arthritis & rheumatology (Hoboken, N.J.), 2021-11, Vol.73 (11), p.1976-1985

2021

Volltextzugriff (PDF)

Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients

Journal of clinical medicine, 2022-09, Vol.11 (19), p.5560

2022

Volltextzugriff (PDF)

IRAK1 functional genetic variant affects severity of septic shock

Critical care medicine, 2010-12, Vol.38 (12), p.2287-2294

2010

Volltextzugriff (PDF)

Outcome of Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients: A Reappraisal of Indications for Organ Failure Supports

Journal of clinical oncology, 2006-02, Vol.24 (4), p.643-649

2006

Volltextzugriff (PDF)

Ten things ICU specialists need to know about platelet transfusions

Intensive care medicine, 2024-08

2024

Volltextzugriff (PDF)

Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation

Blood, 2003-05, Vol.101 (9), p.3436-3443

2003

Volltextzugriff (PDF)

Multidrug-resistant bacteria in the grey shades of immunosuppression

Intensive care medicine, 2023-02, Vol.49 (2), p.216-218

2023

Volltextzugriff (PDF)

High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center

Transfusion (Philadelphia, Pa.), 2014-02, Vol.54 (2), p.389-397

2014

Volltextzugriff (PDF)

Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients

Scientific reports, 2021-06, Vol.11 (1), p.11886-11886, Article 11886

2021

Volltextzugriff (PDF)

Potential role for interferon gamma in the treatment of recurrent ventilator-acquired pneumonia in patients with COVID-19: a hypothesis

Intensive care medicine, 2021-05, Vol.47 (5), p.619-621

2021

Volltextzugriff (PDF)

Protective Effects of FCGR2A Polymorphism in Invasive Pneumococcal Diseases

Chest, 2012-12, Vol.142 (6), p.1474-1481

2012

Volltextzugriff (PDF)

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Science (American Association for the Advancement of Science), 2020-08, Vol.369 (6504), p.718-724

2020

Volltextzugriff (PDF)

Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium—A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study

Journal of clinical oncology, 2013-08, Vol.31 (22), p.2810-2818

2013

Volltextzugriff (PDF)

Platelet activation in critically ill COVID-19 patients

Annals of intensive care, 2021-07, Vol.11 (1), p.113-113, Article 113

2021

Volltextzugriff (PDF)

What really matters with thrombocytopenia: absolute value, timing, etiology or management? Author's reply

Intensive care medicine, 2024-02, Vol.50 (2), p.306-307

2024

Volltextzugriff (PDF)

1 – 25 von 321

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(310)
Mit Volltextzugriff
(302)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Intensive Care Medicine
(49)
Annals Of Intensive Care
(29)
Critical Care
(26)
Critical Care Medicine
(21)
Resuscitation
(14)
American Journal Of Respiratory And Critical Care Medicine
(7)
Chest
(7)
Transfusion
(6)
Blood
(5)
Journal Of Clinical Oncology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality

Infectious complications in out-of-hospital cardiac arrest patients in the therapeutic hypothermia era

Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19

Impact of colonization with multidrug-resistant bacteria on the risk of ventilator-associated pneumonia in septic shock

End of life decisions in immunocompromised patients with acute respiratory failure

Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study

Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma

Impact of early ICU admission for critically ill cancer patients: Post-hoc analysis of a prospective multicenter multinational dataset

Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality

Sepsis-induced expansion of granulocytic myeloid-derived suppressor cells promotes tumour growth through Toll-like receptor 4

Lupus Anticoagulant Single Positivity During the Acute Phase of COVID‐19 Is Not Associated With Venous Thromboembolism or In‐Hospital Mortality

Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients

IRAK1 functional genetic variant affects severity of septic shock

Outcome of Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients: A Reappraisal of Indications for Organ Failure Supports

Ten things ICU specialists need to know about platelet transfusions

Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation

Multidrug-resistant bacteria in the grey shades of immunosuppression

High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center

Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients

Potential role for interferon gamma in the treatment of recurrent ventilator-acquired pneumonia in patients with COVID-19: a hypothesis

Protective Effects of FCGR2A Polymorphism in Invasive Pneumococcal Diseases

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium—A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study

Platelet activation in critically ill COVID-19 patients

What really matters with thrombocytopenia: absolute value, timing, etiology or management? Author's reply

Suchergebnisse filtern